News Image

What's going on in today's pre-market session

By Mill Chart

Last update: Feb 3, 2023

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Pre-market gainers

TickerChangeComment
GENE174.0%GENETIC TECH LTD-SP ADR's (NASDAQ:GENE) stock price increased by 174.0% to $2.77. A press release (GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer) was released earlier today.
RSLS138.0%RESHAPE LIFESCIENCES INC's (NASDAQ:RSLS) shares rose 138.0% to $15.0 during Friday's pre-market session. In the last month the stock lost 29.21%.
MGTA54.83%MAGENTA THERAPEUTICS INC's (NASDAQ:MGTA) shares rose 54.83% to $0.87 during Friday's pre-market session. In the last month the share price increased with 29.11%.
GRCL30.05%GRACELL BIOTECHNOLOGIES-ADR (NASDAQ:GRCL) rose 30.05% to $2.77 during Friday's pre-market session. The stock is trading 40.67% lower than 3 months ago.
JWN27.77%NORDSTROM INC's (NYSE:JWN) shares rose 27.77% to $27.01 during Friday's pre-market session. Shareholders saw the stock price going 27.2% higher in the past month.
SIDU19.43%SIDUS SPACE INC-CL A's (NASDAQ:SIDU) shares rose 19.43% to $0.48. Yesterday the company had a press release: Sidus Space, Inc. Announces Closing of $5.2 Million Public Offering and Full Exercise of Underwriters’ Over-Allotment Option.
BGXX18.87%BRIGHT GREEN CORP (NASDAQ:BGXX) rose 18.87% to $1.26 during Friday's pre-market session. Only yesterday these shares were declining by -25.35%, so we see a bit of recovery today. Two days ago the company had a press release: Bright Green Announces Plans to Raise $500 Million Under EB-5 Capital Program.
AWH15.41%ASPIRA WOMEN'S HEALTH INC's (NASDAQ:AWH) stock price is advancing with 15.41% to a price of $0.51. NASDAQ:AWH seems to be recovering from a -13.73% loss in the previous session.
QTEK14.61%QUALTEK SERVICES INC-A's (NASDAQ:QTEK) stock price is advancing with 14.61% to a price of $0.47. Prices are quite volatile here as yesterday NASDAQ:QTEK closed with a -14.58% loss.
SONM13.21%SONIM TECHNOLOGIES INC (NASDAQ:SONM) rose 13.21% to $0.6 during Friday's pre-market session. In the last 3 months the share price increased with 20.51%.

For the full premarket gainers list go to our premarket gainers screener.

Pre-market losers

TickerChangeComment
EDBL-44.31%EDIBLE GARDEN AG INC's (NASDAQ:EDBL) stock price is declining with 44.31% to a price of $4.65. Yesterday's drop of -28.63% continued in today's pre-market session with another decline of 44.31% Yesterday the company had a press release: Edible Garden Announces Pricing of Upsized $10.2 Million Underwritten Public Offering.
DNA.W-37.21%GINKGO BIOWORKS -CW27's (NYSE:DNA.W) shares fell 37.21% to $0.18 during Friday's pre-market session. NYSE:DNA.W already had a hard day yesterday: closing -11.1% lower during the regular session.
VINO-37.04%GAUCHO GROUP HOLDINGS INC's (NASDAQ:VINO) stock price decreased by 37.04% to $3.4. Prices are quite volatile now: this is a reversal from yesterday's 339.0% gain.
TENX-28.51%TENAX THERAPEUTICS INC's (NASDAQ:TENX) stock price is declining with 28.51% to a price of $1.58. After running up 30.77% in yesterday's session, NASDAQ:TENX is pulling back pre-market.
SMMT-27.84%SUMMIT THERAPEUTICS INC's (NASDAQ:SMMT) shares fell 27.84% to $2.8. In the last month the stock lost 28.28%.
CLLS-24.54%CELLECTIS - ADR's (NASDAQ:CLLS) stock price decreased by 24.54% to $2.46. A press release (Cellectis Announces Pricing of Follow-On Offering) was released earlier today.
BILL-21.34%BILL.COM HOLDINGS INC's (NYSE:BILL) stock price is declining with 21.34% to a price of $101.4. A press release (BILL Reports Second Quarter Fiscal Year 2023 Financial Results) was released yesterday.
IVC-19.67%INVACARE CORP's (NYSE:IVC) stock price is declining with 19.67% to a price of $0.53. A press release (Invacare Corporation Takes Action to Strengthen Its Financial Position and Drive Long-Term Growth Through Voluntary Prearranged Chapter 11 Cases That Do Not Include Its International Operations) was released two days ago.
SNCE-18.1%SCIENCE 37 HOLDINGS INC's (NASDAQ:SNCE) stock price is declining with 18.1% to a price of $0.51. After yesterdays gain of 15.18%, it goes down with 18.1% in today's pre-market session. A press release (Science 37 Acquires Vault Health’s Life Sciences Platform To Bolster its Metasite Capabilities) was released yesterday.
HLBZW-13.79%HELBIZ INC-CW24's (NASDAQ:HLBZW) shares fell 13.79% to $0.05. Shareholders saw the stock price going 29.18% higher in the past 3 months.

To see the full list of premarket losers you can use our premarket losers screener.

Back

ASPIRA WOMEN'S HEALTH INC

NASDAQ:AWH (5/2/2024, 7:00:01 PM)

3.2131

-0.01 (-0.21%)

AWH News

News Image24 days ago - Aspira Women's Health Inc.Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California

Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, and Medicaid...

News Imagea month ago - InvestorPlaceAWH Stock Earnings: Aspira Womens Health Beats EPS, Misses Revenue for Q4 2023

AWH stock results show that Aspira Womens Health beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

News Imagea month ago - Aspira Women's Health Inc.Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results

2023 OvaSuite revenue of $9.2 million, an increase of 15% year-over-year 2023 OvaSuite volume of 23,990 units, an increase of 12% year-over-year Cash...

News Imagea month ago - Aspira Women's Health Inc.Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference

AUSTIN, Texas, March 21, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s...

News Image2 months ago - Aspira Women's Health Inc.Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024

AUSTIN, Texas, March 11, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s...

News Image2 months ago - Aspira Women's Health Inc.Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference

AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s...

News Image3 months ago - Aspira Women's Health Inc.Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)

AUSTIN, Texas, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company...

News Image3 months ago - OptimizeRx CorporationOptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
News Image5 months ago - Aspira Women's Health Inc.Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024

AUSTIN, Texas, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or “the Company”) (Nasdaq: AWH), a bio-analytical based women’s...

News Image5 months ago - Aspira Women's Health Inc.Aspira Women’s Health to Participate in Corporate Access Events During JP Morgan Healthcare Conference Week 2024

Aspira management will be available for meetings in San Francisco (January 8-10, 2024) AUSTIN, Texas, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Aspira Women’s...

News Image5 months ago - Aspira Women's Health Inc.Aspira Women’s Health Provides a Development Update on its Portfolio of Noninvasive Tests for Endometriosis

Data supports EndoCheck™ to be the first blood test for the identification of localized endometriosis, including endometrioma Platform migration to begin...

News Image5 months ago - Aspira Women's Health Inc.Aspira Women’s Health Secures Reimbursement for Ova1Plus(R) from California Medicaid (Medi-Cal)

California Medicaid (Medi-Cal) added Ova1Plus(R) to its fee schedule at $897 per test...

AWH Links
Follow us for more